Check out our most popular compounded medications! Get Started
Dashboard
Formulas

Naltrexone HCl 100 mg/ml Topical Gel

FDA-approved generic
Dose form
Topical Gel
Active ingredients
Naltrexone Hydrochloride
For prescribers
Prescription details
RxThis formula
Dose formSee below
Quantity____
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription detailsOrder form
Controlled substance: e-prescribe (EPCS) from your EHR. Faxed and phoned prescriptions cannot be accepted for this preparation.
Send it from your EHR, or fax to (401) 284-4506. How to e-prescribe this formula
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
To prescribe, you must be a verified prescriber.
To prescribe, you must be in a state where we hold an active out-of-state pharmacy license.
Starting at
Fill my prescription
Fill my prescription
Requires a prescription from your own provider. Bayview is a pharmacy and does not prescribe.
Save 15% on every refill when you enroll in Automatic Refills
Ships within 1 to 2 business days after pharmacist verification
HSA and FSA eligible
Check if we ship to your state
No prescription yet?

Get a sheet with everything your doctor needs to prescribe this and send it to Bayview.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.

For prescribersSign in for prescription details and order forms.
Compounded preparations are prepared by Bayview pursuant to a prescription for an individual patient. They are not FDA-approved and have not been evaluated by FDA for safety or effectiveness.
Naltrexone Hydrochloride
Topical Gel
6427079ea64324c0b8518f17
Service area

Can we ship this formula to your state?

Bayview fills prescriptions for patients in Connecticut, Florida, Maine, Massachusetts, New Hampshire, New Jersey, Pennsylvania and Rhode Island. New York patients are served on a limited basis while nonresident pharmacy registration is pending.

Check your state

Available in

Tap a state to check it.

Our current service area

Currently licensed Limited basis, registration pending Not available for this formula Not currently licensed

Select a state on the map or use the checker.

Prepared to a prescriber's order for one patient. Not FDA-approved.

This formulation

This is a compounded topical gel containing naltrexone hydrochloride, prepared to a prescriber's order for one patient. Compounded preparations are not FDA-approved.

FDA product listings

These listings cover every salt or ester form of each drug in the FDA National Drug Code Directory.

FDA-approved products containing naltrexone are listed in tablet form. It is also a component of FDA-approved kits.

Storage category and dating

Gel bases can be aqueous or nonaqueous, and USP <795> classifies the preparation by its water activity. Aqueous preparations carry shorter default beyond-use dates than nonaqueous ones. The date printed on the label is the one to follow.

Sources

Why prescribers order this

Compounded drugs are not FDA-approved. This means that FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they reach patients.

Naltrexone is an opioid receptor blocker that a pharmacy may compound when a prescriber orders it.

About this ingredient

Naltrexone is a pure opioid antagonist: it binds opioid receptors and blocks the effects of opioids without producing opioid effects of its own. Manufactured products include naltrexone hydrochloride tablets, indicated for alcohol dependence and for blocking the effects of opioids taken from outside the body, as part of an addiction management plan; Vivitrol extended-release injectable suspension, indicated for alcohol dependence in patients able to abstain and for prevention of relapse to opioid dependence after detoxification; and Contrave, which combines naltrexone with bupropion and is indicated, with a reduced-calorie diet and increased physical activity, to reduce excess body weight and maintain weight reduction long term in adults with obesity, or overweight with at least one weight-related condition. A prescriber might order naltrexone compounded in a strength or dosage form that is not manufactured. Published reports describe low-dose naltrexone as often made by compounding pharmacies; its uses are not FDA-approved indications. Compounded preparations are not FDA-approved and require a prescription.

Safety and interactions

The current naltrexone tablet label has no boxed warning. Do not take naltrexone if you take opioid pain medicines, depend on opioids (including methadone or buprenorphine), are in opioid withdrawal, or have a positive opioid urine screen. Taking it while opioids are in your system can cause sudden, severe withdrawal; the label recommends an opioid-free period before starting. After stopping, or if you try to override the blockade with large opioid doses, overdose can be fatal, so ask about naloxone or nalmefene. The label also warns of hepatitis and liver injury, and of reported depression and suicidal thinking. It does not cause a disulfiram-like reaction with alcohol. The label advises use in pregnancy only if the benefit justifies the risk, and LactMed says naltrexone passes into milk minimally and is not a reason to stop breastfeeding. Talk to your prescriber or pharmacist about side effects.

Naltrexone is a competitive opioid receptor antagonist; its blockade is surmountable, and it causes no tolerance or dependence. Oral absorption is about 96%, but extensive first-pass metabolism leaves oral bioavailability of 5 to 40%. Activity is attributed to both parent drug and 6-beta-naltrexol. Peak levels occur within an hour, protein binding is 21%, and mean half-lives are about 4 hours for naltrexone and 13 hours for 6-beta-naltrexol, with mainly renal excretion. Labeled indications: alcohol dependence and blockade of exogenous opioids (tablets); alcohol dependence and prevention of relapse to opioid dependence after detoxification (Vivitrol); weight reduction and maintenance with diet and physical activity in adults with obesity, or overweight with a weight-related comorbidity (Contrave, with bupropion). StatPearls lists cholestatic pruritus in adults as an off-label use, which is not an FDA-approved indication. Prescribers have ordered compounded low-dose naltrexone, an off-label use, for fibromyalgia and other chronic pain conditions; these are not FDA-approved indications, and a 2023 systematic review of low-dose naltrexone in fibromyalgia described the evidence as preliminary and drawn from few, small studies, with reported insomnia, vivid dreams and headache. Dosing is per prescriber. Confirm the patient is opioid-free, monitor liver function and mood, and counsel on overdose risk.

Sources

Using and storing

How it is used

Wash your hands. Apply the amount on your label to clean, dry skin and spread it in a thin layer. For a metered pump, your label states the number of presses. For a dosing syringe, push the plunger to the mark. Let the gel dry before covering with clothing. Wash your hands afterward and keep the site from touching other people until it has dried. Do not apply to broken skin unless told to.

Storing it

A gel can have a nonaqueous or a water-based base, and USP <795> sets its default beyond-use date by water content, not by the word gel. A nonaqueous gel usually carries a beyond-use date of up to 180 days at room temperature or refrigerated. A water-based gel carries up to 35 days with a preservative, or 14 days refrigerated without one. Your label states which applies. Keep the container closed, away from heat and open flame if it contains alcohol, out of reach of children, and discard after the beyond-use date on your label.

Sources

Prescribing and ordering FAQs

Formula Information

A small arrow pointing down

Drug Interactions

A small arrow pointing down

How Does it Work

A small arrow pointing down

Frequently Asked Questions

A small arrow pointing down

About this compounded preparation

This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.

A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.

Formulas and/or material listed are not to be interpreted as a promise, guarantee or claim of therapeutic efficacy or safety. The information contained herein is not intended to replace or substitute for conventional medical care, or encourage its abandonment. Every patient is unique, and formulas should be adjusted to meet their individual needs.

No compounded medications are reviewed by the FDA for safety or efficacy.
For prescribers

How to e-prescribe this formula

Controlled substance: e-prescribe only (EPCS). Faxed, phoned, and handwritten prescriptions cannot be filled. Rhode Island law (R.I. Gen. Laws § 21-28-3.18) requires Schedule II to V prescriptions to be transmitted electronically.
1

Find Bayview in your EHR's pharmacy directory

Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.

NCPDP4106882NPI1750455143Address3844 Post Rd, Warwick, RI 02886Phone(401) 284-4505Fax(401) 284-4506
2

Enter the formula as a compound

Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.

Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.

3

Copy the prescription details

RxFormula name
Dose formDose form
Quantity________
SigAs directed by prescriber
Refills____
PharmacyBayview Pharmacy, Warwick RI, NCPDP 4106882
Copy prescription details

Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.

4

Send it

Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.

Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.

Do not use Notes to Pharmacy for the formula. Some EHRs keep that field internal and never transmit it. A prescription that arrives without the formula is delayed while we call your office.

Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.

Naltrexone HCl 100 mg/ml Topical Gel
Topical Gel
60 g
controlled

Apply topically to affected area(s)

Twice daily